Market Closed -
Nyse
01:30:01 04/05/2024 am IST
|
5-day change
|
1st Jan Change
|
23.82
USD
|
+0.93%
|
|
-0.13%
|
+2.94%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,933
|
4,383
|
6,009
|
4,404
|
5,589
|
5,766
|
-
|
-
|
Enterprise Value (EV)
1 |
4,264
|
5,607
|
7,586
|
6,033
|
7,249
|
7,286
|
7,320
|
7,321
|
P/E ratio
|
33.4
x
|
59.1
x
|
29.6
x
|
23.9
x
|
47.2
x
|
32.2
x
|
26.8
x
|
-
|
Yield
|
-
|
0.28%
|
1.03%
|
1.76%
|
-
|
1.38%
|
1.48%
|
1.51%
|
Capitalization / Revenue
|
1.6
x
|
2.36
x
|
2.5
x
|
1.73
x
|
2.4
x
|
2.39
x
|
2.27
x
|
2.15
x
|
EV / Revenue
|
2.32
x
|
3.02
x
|
3.16
x
|
2.37
x
|
3.11
x
|
3.02
x
|
2.88
x
|
2.73
x
|
EV / EBITDA
|
10.2
x
|
13.3
x
|
14.5
x
|
11.5
x
|
15
x
|
13.9
x
|
12.8
x
|
11.7
x
|
EV / FCF
|
-
|
-
|
27.1
x
|
24.3
x
|
25.7
x
|
24.6
x
|
21.9
x
|
19.4
x
|
FCF Yield
|
-
|
-
|
3.69%
|
4.11%
|
3.89%
|
4.07%
|
4.56%
|
5.15%
|
Price to Book
|
1.32
x
|
1.89
x
|
2.41
x
|
1.88
x
|
2.4
x
|
2.36
x
|
2.28
x
|
2.17
x
|
Nbr of stocks (in thousands)
|
2,51,099
|
2,47,213
|
2,47,503
|
2,42,086
|
2,41,516
|
2,42,064
|
-
|
-
|
Reference price
2 |
11.68
|
17.73
|
24.28
|
18.19
|
23.14
|
23.82
|
23.82
|
23.82
|
Announcement Date
|
26/02/20
|
24/02/21
|
22/02/22
|
21/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,836
|
1,854
|
2,400
|
2,549
|
2,333
|
2,410
|
2,540
|
2,679
|
EBITDA
1 |
416.7
|
422.6
|
524.9
|
526.6
|
482.3
|
525.5
|
572.3
|
627.7
|
EBIT
1 |
262
|
380.4
|
485.2
|
485
|
315.6
|
483.5
|
530.4
|
579.9
|
Operating Margin
|
14.27%
|
20.52%
|
20.22%
|
19.02%
|
13.53%
|
20.06%
|
20.88%
|
21.65%
|
Earnings before Tax (EBT)
|
140.9
|
81.1
|
251.7
|
272
|
129.1
|
-
|
-
|
-
|
Net income
1 |
92.2
|
75.7
|
203.3
|
187.2
|
118.1
|
216
|
256
|
-
|
Net margin
|
5.02%
|
4.08%
|
8.47%
|
7.34%
|
5.06%
|
8.96%
|
10.08%
|
-
|
EPS
2 |
0.3500
|
0.3000
|
0.8200
|
0.7600
|
0.4900
|
0.7400
|
0.8900
|
-
|
Free Cash Flow
1 |
-
|
-
|
279.7
|
248.1
|
282.3
|
296.5
|
333.8
|
377
|
FCF margin
|
-
|
-
|
11.66%
|
9.73%
|
12.1%
|
12.3%
|
13.14%
|
14.07%
|
FCF Conversion (EBITDA)
|
-
|
-
|
53.29%
|
47.11%
|
58.53%
|
56.42%
|
58.32%
|
60.06%
|
FCF Conversion (Net income)
|
-
|
-
|
137.58%
|
132.53%
|
239.03%
|
137.27%
|
130.39%
|
-
|
Dividend per Share
2 |
-
|
0.0500
|
0.2500
|
0.3200
|
-
|
0.3275
|
0.3534
|
0.3600
|
Announcement Date
|
26/02/20
|
24/02/21
|
22/02/22
|
21/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
646.9
|
680.2
|
676.9
|
618.5
|
573.8
|
574.4
|
586.1
|
599.3
|
573.4
|
575
|
597.6
|
629.4
|
608.6
|
601.8
|
620.1
|
EBITDA
1 |
122.4
|
144.8
|
140.4
|
133.5
|
107.9
|
112.3
|
116.1
|
134.1
|
119.8
|
127
|
125.9
|
140
|
131.5
|
137.7
|
138.2
|
EBIT
1 |
111.4
|
134.2
|
130.1
|
122.9
|
97.8
|
102.8
|
106
|
122.3
|
77.8
|
116.9
|
115.5
|
129
|
122
|
127.3
|
128.1
|
Operating Margin
|
17.22%
|
19.73%
|
19.22%
|
19.87%
|
17.04%
|
17.9%
|
18.09%
|
20.41%
|
13.57%
|
20.33%
|
19.33%
|
20.49%
|
20.05%
|
21.16%
|
20.66%
|
Earnings before Tax (EBT)
|
37.9
|
76.4
|
87.5
|
69.8
|
38.3
|
59.9
|
48
|
-16.4
|
37.6
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
3.9
|
56.1
|
63.6
|
53.2
|
12.7
|
42.9
|
29.9
|
-31.8
|
77.1
|
56
|
51.1
|
63.9
|
52.9
|
62.1
|
59.9
|
Net margin
|
0.6%
|
8.25%
|
9.4%
|
8.6%
|
2.21%
|
7.47%
|
5.1%
|
-5.31%
|
13.45%
|
9.74%
|
8.55%
|
10.15%
|
8.69%
|
10.32%
|
9.66%
|
EPS
2 |
0.0100
|
0.2300
|
0.2500
|
0.2200
|
0.0500
|
0.1800
|
0.1200
|
-0.1300
|
0.3200
|
0.2300
|
0.1700
|
0.2250
|
0.0500
|
0.2600
|
0.2500
|
Dividend per Share
2 |
0.0800
|
0.0800
|
0.0800
|
0.0800
|
0.0800
|
0.0800
|
-
|
0.0800
|
-
|
-
|
0.0800
|
0.0800
|
0.0900
|
-
|
-
|
Announcement Date
|
22/02/22
|
27/04/22
|
27/07/22
|
26/10/22
|
21/02/23
|
26/04/23
|
26/07/23
|
25/10/23
|
20/02/24
|
29/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,331
|
1,224
|
1,577
|
1,630
|
1,661
|
1,520
|
1,554
|
1,555
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.194
x
|
2.895
x
|
3.004
x
|
3.095
x
|
3.443
x
|
2.893
x
|
2.716
x
|
2.478
x
|
Free Cash Flow
1 |
-
|
-
|
280
|
248
|
282
|
297
|
334
|
377
|
ROE (net income / shareholders' equity)
|
10.5%
|
10.6%
|
14.4%
|
14.5%
|
13.4%
|
14.6%
|
15%
|
15.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.21%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
2,820
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
8.880
|
9.390
|
10.10
|
9.690
|
9.640
|
10.10
|
10.40
|
11.00
|
Cash Flow per Share
2 |
0.6600
|
1.050
|
1.320
|
1.200
|
1.380
|
1.240
|
1.370
|
-
|
Capex
1 |
29.7
|
28.8
|
46.3
|
47.8
|
52.7
|
56.8
|
52.5
|
58.5
|
Capex / Sales
|
1.62%
|
1.55%
|
1.93%
|
1.87%
|
2.26%
|
2.36%
|
2.07%
|
2.18%
|
Announcement Date
|
26/02/20
|
24/02/21
|
22/02/22
|
21/02/23
|
20/02/24
|
-
|
-
|
-
|
Last Close Price
23.82
USD Average target price
27.89
USD Spread / Average Target +17.08% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.94% | 5.77B | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|